Lifelong Protection: Monitoring Your Kidneys and Bones
At a Glance
People with HHRH need lifelong, individualized monitoring because phosphate loss can weaken bones while excess urine calcium can cause kidney stones and calcium deposits in the kidneys. Blood and urine tests, ultrasound, kidney-function checks, and bone monitoring help guide safe care.
Managing Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) or NPHLOP1 is a lifelong commitment. Because the kidney “leak” is caused by your genetics, the goal of care shifts from diagnosis to long-term preservation—protecting your kidneys from structural damage and your bones from osteomalacia and fractures. While treatment with oral phosphate is effective, it requires clinician-directed “fine-tuning” through regular surveillance [1][2].
Your Individualized Surveillance Framework
Because HHRH is rare and varies by genotype, there is no single “one-size-fits-all” schedule for testing. Instead, your care team (usually an endocrinologist and a nephrologist) will tailor your monitoring based on your age, symptoms, and stone history.
1. Laboratory Monitoring (Blood and Urine)
Regular labs guide your phosphate dosing and ensure kidney safety [2][3].
- Serum Phosphate & Alkaline Phosphatase: Monitored to ensure your bones have enough minerals to stay strong [2].
- Urine Calcium: Checked (often via a 24-hour collection in adults, or spot tests in children) to ensure your hypercalciuria is managed [4].
- PTH (Parathyroid Hormone): Phosphate supplements can sometimes cause PTH to rise. Monitoring this helps prevent “secondary hyperparathyroidism” [5].
- Creatinine & eGFR: These tests measure your overall kidney function and help detect early signs of Chronic Kidney Disease (CKD) [6][7].
2. Kidney Imaging (Renal Ultrasound)
Calcium deposits (nephrocalcinosis) and stones are frequently found in individuals with biallelic HHRH [8].
- Ultrasound: This is a preferred surveillance tool because it does not use radiation. It allows your doctor to see if new stones are forming or if calcium deposits in the kidney tissue are growing [9][10]. The exact frequency of ultrasounds will be customized to your clinical needs.
3. Skeletal Health (DXA Scans)
For adults, DXA scans are often used to monitor bone mineral density. However, low DXA values during active osteomalacia do not automatically equal typical osteoporosis; diagnosis requires your doctor to interpret your DXA alongside your clinical picture and mineral labs [2][11]. In children, surveillance focuses on growth charts and physical exams for rickets-related bone pain or bowing.
The Risk of Chronic Kidney Disease (CKD)
Long-term survivorship in HHRH involves protecting the kidneys from the cumulative damage of recurrent stones and nephrocalcinosis. Recurrent stones can contribute to kidney injury, which may slowly decrease your kidney’s ability to filter blood [12][7].
- Hydration: Maintaining an individualized fluid or urine-volume goal helps dilute the urine. Discuss appropriate fluid intake with your doctor, as indiscriminate high fluid intake can be unsafe for people with reduced kidney function or heart conditions [13][6].
- Adherence: Following your tailored phosphate and adjunctive stone therapies is crucial for managing the calcium load on the kidneys.
Triage: When to Seek Medical Care
Kidney stones are a common complication, but they require different levels of care depending on your symptoms [14][10]:
- Prompt Clinical Contact: If you experience persistent or recurrent flank pain, painful urination (dysuria), reduced urine output, or visible blood in your urine, contact your care team promptly for advice.
- Immediate Emergency Care: Go to an emergency department immediately if you experience any of the following:
- Fever and Flank Pain: A fever combined with pain in your side or back can signal an infected, obstructed kidney. This is a life-threatening emergency [14][15].
- Inability to Urinate (Anuria): Indicates a potential severe blockage of the urinary tract [16].
- Uncontrolled Pain or Vomiting: If you cannot keep fluids down or your pain cannot be managed at home [10][17].
- Heavy Bleeding or Clots: While mild blood is common with stones, heavy bleeding warrants urgent assessment [10].
By staying engaged with your medical team through regular, individualized monitoring, you can proactively manage the risks of HHRH and maintain your long-term health [1].
Common questions in this guide
What monitoring tests are needed for HHRH?
How often should someone with HHRH have a kidney ultrasound?
Does a low DXA scan prove that I have osteoporosis?
Which kidney-stone symptoms require emergency care?
Can phosphate treatment affect parathyroid hormone or kidney safety?
How can HHRH increase the risk of chronic kidney disease?
What is the right fluid goal for someone with HHRH?
Get notified when new evidence is published on nephrolithiasis/osteoporosis, hypophosphatemic.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.
Bergwitz C, Miyamoto KI
Pflugers Archiv : European journal of physiology 2019; (471(1)):149-163 doi:10.1007/s00424-018-2184-2.
PMID: 30109410 - 2
Rickets guidance: part II-management.
Haffner D, Leifheit-Nestler M, Grund A, Schnabel D
Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.
PMID: 35352187 - 3
FGF23 and Associated Disorders of Phosphate Wasting.
Gohil A, Imel EA
Pediatric endocrinology reviews : PER 2019; (17(1)):17-34 doi:10.17458/per.vol17.2019.gi.fgf23anddisordersphosphate.
PMID: 31599133 - 4
An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).
Zhu Z, Bo-Ran Ho B, Chen A, et al.
Kidney international 2024; (105(5)):1058-1076 doi:10.1016/j.kint.2024.01.031.
PMID: 38364990 - 5
Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.
Brunkhorst M, Brunkhorst L, Martens H, et al.
Kidney international 2025; (107(1)):116-129 doi:10.1016/j.kint.2024.08.035.
PMID: 39461557 - 6
Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors.
Colares Neto GP, Ide Yamauchi F, Hueb Baroni R, et al.
Journal of the Endocrine Society 2019; (3(5)):1053-1061 doi:10.1210/js.2018-00338.
PMID: 31065622 - 7
Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.
Wagner CA, Rubio-Aliaga I, Hernando N
Pediatric nephrology (Berlin, Germany) 2019; (34(4)):549-559 doi:10.1007/s00467-017-3873-3.
PMID: 29275531 - 8
Hereditary Hypophosphatemic Rickets with Hypercalciuria Presenting with Enthesopathy, Renal Cysts, and High Serum c-Terminal FGF23: Single-Center Experience and Systematic Review.
Dodamani MH, Memon SS, Karlekar M, et al.
Calcified tissue international 2024; (114(2)):137-146 doi:10.1007/s00223-023-01156-2.
PMID: 37981601 - 9
Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) Presenting with Genu Valgum Deformity: Treatment with Phosphate Supplementation and Surgical Correction.
Colazo JM, Reasoner SA, Holt G, et al.
Case reports in endocrinology 2020; (2020()):1047327 doi:10.1155/2020/1047327.
PMID: 32695531 - 10
The evaluation and management of urolithiasis in the ED: A review of the literature.
Gottlieb M, Long B, Koyfman A
The American journal of emergency medicine 2018; (36(4)):699-706 doi:10.1016/j.ajem.2018.01.003.
PMID: 29321112 - 11
Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).
Stürznickel J, Heider F, Delsmann A, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(8)):1580-1591 doi:10.1002/jbmr.4630.
PMID: 35689455 - 12
Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic <italic>SLC34A3</italic> and Monoallelic <italic>SLC3A1</italic> Pathogenic Variants - Who Is "The Culprit"?
Olarewaju BA, Sabrowsky S, Shurrab S, et al.
Kidney & blood pressure research 2026; (51(1)):280-284 doi:10.1159/000551270.
PMID: 41849633 - 13
Phosphate matters when investigating hypercalcemia: a mutation in SLC34A3 causing HHRH
Tang AR, Hinz LE, Khan A, Kline GA
Endocrinology, diabetes & metabolism case reports 2019; (2019(1)):1-6 doi:10.1530/EDM-19-0058.
PMID: 31352694 - 14
Treatment of the Infected Stone.
Marien T, Miller NL
The Urologic clinics of North America 2015; (42(4)):459-72.
PMID: 26475943 - 15
Determinants of pyelonephritis onset in patients with obstructive urolithiasis.
Abi Tayeh G, Safa A, Sarkis J, et al.
Urologia 2022; (89(1)):100-103 doi:10.1177/03915603211035244.
PMID: 34338097 - 16
2022 Recommendations of the AFU Lithiasis Committee: Specific cases - chronic kidney disease, bilateral stones, and solitary kidney.
Meria P, Almeras C,
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2023; (33(14)):875-882 doi:10.1016/j.purol.2023.08.006.
PMID: 37918987 - 17
Exploring the Efficacy and Safety of Ketamine for Managing Acute Renal Colic in Emergency Departments: A Systematic Review of Recent Clinical Trials.
Sukhram SD, Yilmaz G, Erichsen S, Vassilevich S
International journal of molecular sciences 2025; (26(1)) doi:10.3390/ijms26010371.
PMID: 39796226
This page is for informational purposes only and does not constitute medical advice. Your endocrinologist and nephrologist should tailor your laboratory, imaging, fluid, and emergency-care plan.